• Stanislaw Klek, Isabel Martinez Del Rio Requejo, Gil Hardy, Liza Mei P Francisco, Osman Abbasoglu, Juan Carlos Ayala Acosta, Luis Miguel Becerra Granados, Kurt Boeykens, Sharon Carey, Michael Chourdakis, Charlene Compher, Joeri De Cloet, Sergiej Dubrov, Catalina Fuentes, Ana Karina García Sámano, María Eloisa García Velasquez, Cezanne Goos, José Guillermo Gutierrez Reyes, Lee V Joon, Andrius Klimasauskas, Regina Komsa, Zeljko Krznaric, Dina Ljubas, Claudia P Maza Moscoso, Rosa Larreategui, Liliana Mirea, Remy Meier, Ibolya Nyulasi, Irtun Oivind, Marina Panisic-Sekeljic, Kalliopi Anna Poulia, Henrik Højgaard Rasmussen, Patricia Savino, Pierre Singer, Peter Tamasi, Mehmet Uyar, Nguyen Viet Quynh Thu, Dan Waitzberg, Arved Weimann, Theodoric Wong, Jianchun Yu, Paulina Wojcik, and Stephane Schneider.
• Surgical Oncology Clinic, Maria Sklodowska-Curie National Cancer Research Institute, Krakow, Poland. Electronic address: st.klek@gmail.com.
• Nutrition. 2024 Feb 26; 123: 112396112396.

ObjectiveParenteral nutrition represents a therapeutic option for patients with type 3 intestinal failure. If used exclusively, parenteral nutrition has to be complete to provide all essential nutrients. The aim was to assess the availability of parenteral nutrition in all parts of the world, to better comprehend the global situation, and to prepare an action plan to increase access to parenteral nutrition.MethodsAn international survey using an electronic questionnaire was conducted in August 2019 and repeated in May 2022. An electronic questionnaire was sent to 52 members or affiliates of the International Clinical Nutrition Section of the American Society for Parenteral and Enteral Nutrition. Questions addressed the availability of parenteral nutrition admixtures and their components, reimbursement, and prescribing pre- and post-COVID-19 pandemic. All participating countries were categorized by their economic status.ResultsThirty-six country representatives responded, answering all questions. Parenteral nutrition was available in all countries (100%), but in four countries (11.1%) three-chamber bags were the only option, and in six countries a multibottle system was still used. Liver-sparing amino acids were available in 18 (50%), kidney-sparing in eight (22.2%), and electrolyte-free in 11 (30.5%) countries (30.5%). In most countries (n = 28; 79.4%), fat-soluble and water-soluble vitamins were available. Trace elements solutions were unavailable in four (11.1%) countries. Parenteral nutrition was reimbursed in most countries (n = 33; 91.6%). No significant problems due to the coronavirus pandemic were reported.ConclusionsDespite the apparent high availability of parenteral nutrition worldwide, there are some factors that may have a substantial effect on the quality of parenteral nutrition admixtures. These shortages create an environment of inequality.Copyright © 2024 Elsevier Inc. All rights reserved.

5 keywords...

hide…